Eleuterio Ferrannini

Eleuterio Ferrannini's AcademicInfluence.com Rankings

Philosophy

#1905

World Rank

#3358

Historical Rank

Logic

#353

World Rank

#693

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Eleuterio Ferrannini's Degrees

Doctorate Medicine Consorzio ICoN
PhD Endocrinology and Metabolism Consorzio ICoN

Why Is Eleuterio Ferrannini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eleuterio Ferrannini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease (1991) (4668)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2012) (3751)
Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2014) (2714)
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2013) (2523)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) (2459)
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. (2005) (2400)
Pathogenesis of NIDDM: A Balanced Overview (1992) (2209)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) (1934)
Defining the role of common variation in the genomic and biological architecture of adult human height (2014) (1805)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (2006) (1767)
Insulin resistance in essential hypertension. (1987) (1648)
Type 2 diabetes mellitus (2015) (1613)
The theoretical bases of indirect calorimetry: a review. (1988) (1559)
New genetic loci link adipose and insulin biology to body fat distribution (2014) (1227)
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 (2013) (1128)
Effect of fatty acids on glucose production and utilization in man. (1983) (1100)
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). (1997) (850)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. (2014) (825)
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. (1989) (820)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) (744)
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis (2016) (735)
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. (2005) (719)
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise (2010) (689)
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2015) (654)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005) (652)
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome (1991) (650)
The metabolic syndrome: time for a critical appraisal (2005) (597)
Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man (1983) (575)
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population (2010) (558)
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. (1989) (535)
How to measure insulin sensitivity (1998) (528)
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. (2007) (528)
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors (2015) (526)
Rare and low-frequency coding variants alter human adult height (2016) (511)
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial (2017) (492)
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. (2005) (491)
Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized? (2011) (482)
Diabetes and hypertension: the bad companions (2012) (473)
Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. (1998) (467)
Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. (2002) (451)
Effect of insulin on uric acid excretion in humans. (1995) (440)
Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes (2016) (439)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. (2014) (438)
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. (2003) (428)
Synergistic interaction between exercise and insulin on peripheral glucose uptake. (1981) (408)
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study (1985) (408)
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. (2001) (403)
Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients (2008) (388)
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2008) (385)
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. (2004) (384)
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects (2012) (371)
Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus (1982) (359)
Obesity and insulin resistance in humans: a dose-response study. (1990) (354)
Identification of individuals with insulin resistance using routine clinical measurements. (2005) (353)
Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR) (1996) (351)
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. (2005) (349)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review (2006) (345)
Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement (2007) (334)
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. (1991) (327)
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). (1997) (327)
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study (2003) (326)
The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. (1988) (320)
Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. (2006) (318)
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. (1978) (317)
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. (2001) (314)
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? (2011) (312)
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. (2000) (312)
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids (2013) (308)
Fifty‐two‐week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy (2009) (306)
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. (1983) (297)
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. (2002) (296)
Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance (2013) (295)
Effect of insulin on renal sodium and uric acid handling in essential hypertension. (1996) (292)
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. (2002) (290)
Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes (1987) (290)
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. (1989) (288)
Splanchnic and Peripheral Disposal of Oral Glucose in Man (1983) (283)
Evidence for an association of high blood pressure and hyperinsulinemia in obese man. (1986) (269)
Effect of insulin on the distribution and disposition of glucose in man. (1985) (269)
Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans (2010) (262)
Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition (2015) (258)
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. (1987) (258)
Common Variants of the Novel Type 2 Diabetes Genes CDKAL1 and HHEX/IDE Are Associated With Decreased Pancreatic β-Cell Function (2007) (255)
Metabolic effects of visceral fat accumulation in type 2 diabetes. (2002) (253)
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function (2004) (250)
Hyperinsulinemia and Autonomic Nervous System Dysfunction in Obesity: Effects of Weight Loss (2001) (247)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. (2016) (246)
Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. (2013) (243)
Thyroid disorders in chronic hepatitis C. (2004) (240)
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. (2002) (239)
Beta cell function and its relation to insulin action in humans: a critical appraisal (2004) (236)
Acute Antihyperglycemic Mechanisms of Metformin in NIDDM: Evidence for Suppression of Lipid Oxidation and Hepatic Glucose Production (1994) (234)
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. (1991) (232)
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. (2015) (226)
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. (1983) (214)
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. (1992) (210)
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. (1992) (210)
Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study (2010) (204)
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. (1999) (201)
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes (2009) (199)
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome (2000) (198)
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. (2006) (198)
Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes (2011) (197)
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes (2011) (197)
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology. (2017) (196)
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure underpinning obesity (2017) (193)
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. (2012) (189)
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. (2008) (185)
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility (2015) (185)
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women (2007) (184)
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. (1995) (184)
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors (2019) (183)
Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. (1980) (181)
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives (2004) (180)
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. (2006) (179)
A Phase IIb, randomized, placebo‐controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes (2013) (176)
Insulin resistance, insulin response, and obesity as indicators of metabolic risk. (2007) (176)
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. (2004) (173)
Regulation of hepatic glucose metabolism in humans. (1987) (170)
International textbook of diabetes mellitus (2015) (169)
Impact of Different Bariatric Surgical Procedures on Insulin Action and β-Cell Function in Type 2 Diabetes (2009) (169)
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C (2009) (168)
The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. (2011) (165)
A model of glucose kinetics and their control by insulin, compartmental and noncompartmental approaches (1984) (165)
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. (2006) (165)
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. (1996) (163)
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. (1993) (162)
Impaired Insulin Action on Skeletal Muscle Metabolism in Essential Hypertension (1991) (161)
A comparative study of the in vitro antioxidant activity of statins. (2003) (161)
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. (2004) (160)
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes (2011) (159)
The stunned beta cell: a brief history. (2010) (157)
Insulin resistance, iron, and the liver (2000) (157)
Residual macrovascular risk in 2013: what have we learned? (2014) (157)
Physical Activity and Insulin Sensitivity (2008) (157)
Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity (2014) (156)
Essential hypertension, metabolic disorders, and insulin resistance. (1991) (155)
Essential Hypertension: An Insulin‐Resistant State (1990) (155)
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. (2002) (154)
The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents (1992) (152)
Non-steady state: error analysis of Steele's model and developments for glucose kinetics. (1987) (152)
Autonomic and hemodynamic responses to insulin in lean and obese humans. (1998) (149)
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. (2010) (148)
Thyroid disorders in chronic hepatitis C virus infection. (2006) (147)
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. (1997) (147)
Effect of insulin and glucose on feeding behavior. (1985) (145)
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. (1988) (145)
The kinetics of insulin in man. II. Role of the liver. (1987) (144)
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. (2001) (141)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Personalized Management of Hyperglycemia in Type 2 Diabetes (2013) (139)
beta-cell function in obesity: effects of weight loss. (2004) (136)
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss (2009) (135)
Thiazolidinediones improve beta-cell function in type 2 diabetic patients. (2007) (132)
Hepatitis C virus infection: evidence for an association with type 2 diabetes. (2005) (129)
Interferon-γ-Inducible α-Chemokine CXCL10 Involvement in Graves’ Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists (2006) (128)
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. (2008) (128)
Metabolic and hemodynamic effects of insulin on human hearts. (1993) (127)
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. (2011) (125)
Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat (2008) (122)
CXCR3, CXCL10 and type 1 diabetes. (2014) (122)
Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin (2013) (122)
Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance. (2016) (121)
Mechanism of improvement in glucose metabolism after chronic glyburide therapy. (1984) (121)
Fatty liver index, gamma‐glutamyltransferase, and early carotid plaques (2012) (121)
The Pathogenesis of Non‐Insulin-Dependent Diabetes: AN UPDATE (1982) (119)
Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. (2005) (119)
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. (1996) (118)
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function (2006) (117)
Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset (2009) (116)
Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects (2006) (116)
Insulin: in search of a syndrome (2002) (116)
Prevalence of hypothyroidism and Graves disease in sarcoidosis. (2006) (116)
Time dependence of the interaction between lipid and glucose in humans. (1989) (116)
Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes (2017) (115)
The target of metformin in type 2 diabetes. (2014) (115)
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance (2003) (115)
Direct effect of GLP-1 infusion on endogenous glucose production in humans (2012) (114)
Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories (2018) (114)
The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. (1980) (114)
Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes (2013) (113)
Insulin resistance after surgery: normalization by insulin treatment. (1990) (113)
In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. (1987) (112)
Troglitazone Reduces LDL Oxidation and Lowers Plasma E-selectin Concentration in NIDDM Patients (1998) (111)
High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. (2006) (110)
Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis (1988) (110)
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. (2004) (110)
Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose‐finding study (2013) (109)
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum (2016) (109)
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. (2004) (109)
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. (2000) (109)
Influence of Plasma Glucose and Insulin Concentration on Plasma Glucose Clearance in Man (1982) (109)
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. (1988) (109)
Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients: The DAI Study (2007) (108)
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. (2005) (107)
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease (2012) (107)
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. (2007) (107)
Operation of Randle's Cycle in Patients With NIDDM (1990) (106)
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance (2010) (106)
Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. (1981) (105)
β-Cell function in type 2 diabetes. (2014) (105)
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. (2003) (104)
Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy (1984) (104)
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. (2008) (103)
Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. (2006) (102)
beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. (2005) (102)
Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. (1992) (102)
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes (2014) (101)
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. (2014) (101)
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. (1999) (99)
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. (2012) (99)
Physiological and metabolic consequences of obesity. (1995) (99)
The diabetes pandemic and associated infections: suggestions for clinical microbiology (2018) (97)
Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin (1993) (96)
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study (2008) (96)
Parental history of diabetes is associated with increased cardiovascular risk factors. (1989) (96)
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2007) (95)
Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? (1993) (95)
High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. (2009) (95)
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. (1994) (94)
Differential effect of weight loss on insulin resistance in surgically treated obese patients. (2005) (94)
β‐cell function assessment from modelling of oral tests: an effective approach (2008) (94)
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. (2009) (93)
Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. (1999) (93)
Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. (1994) (92)
Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy (2010) (92)
Consensus statement on the worldwide standardisation of the HbA 1c measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation (2007) (92)
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease (2016) (92)
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. (2003) (92)
Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. (1996) (91)
Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study. (2003) (91)
The kinetics of insulin in man. I. General aspects. (1987) (91)
Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients (2013) (90)
Effect of acute hyperglycemia on insulin secretion in humans. (2002) (90)
Effects of Insulin on Hemodynamics and Metabolism in Human Forearm (1990) (89)
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions. (2007) (89)
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. (1999) (89)
Metabolic syndrome: a solution in search of a problem. (2007) (89)
Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. (1995) (88)
Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity. (2016) (88)
Effects of insulin on hemodynamics and metabolism in human forearm. (1990) (87)
Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes (2008) (87)
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells (2009) (86)
Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. (1978) (86)
Pathophysiology of prediabetes. (2011) (86)
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance. (2006) (86)
Decreased expression of hepatic glucokinase in type 2 diabetes (2014) (85)
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L‐T4 replacement therapy (1999) (85)
Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. (2007) (85)
Thiazolidinediones improve -cell function in type 2 diabetic patients (2007) (85)
Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. (1995) (84)
CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes. (2010) (84)
The association of hypertension, diabetes, and obesity: A review (1989) (83)
Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM (1996) (83)
The Effect of Pioglitazone on the Liver (2006) (83)
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. (2003) (83)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text (2007) (82)
Increase of interferon‐γ‐inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapy (2006) (82)
Association of fasting glucagon and proinsulin concentrations with insulin resistance (2007) (82)
Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. (2001) (82)
Insulin Resistance and Hypersecretion in Obesity (2013) (82)
Insulin Resistance and Hyperinsulinemia: No Independent Relation to Left Ventricular Mass in Humans (2000) (81)
High Values of CXCL10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection (2008) (80)
Primary cell cultures from anaplastic thyroid cancer obtained by fine‐needle aspiration used for chemosensitivity tests (2008) (80)
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. (2008) (80)
Insulin resistance is central to the burden of diabetes. (1997) (79)
Insulin prolongs the QTc interval in humans. (2000) (79)
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. (2004) (79)
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. (2006) (78)
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. (2011) (78)
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. (2011) (77)
Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients (2007) (77)
Insulin Resistance in Diabetic Ketoacidosis (1982) (77)
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus. (2013) (77)
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. (2005) (77)
Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study (2010) (76)
Hypertension, insulin resistance, and the metabolic syndrome. (2004) (75)
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms. (2009) (75)
A Novel Fasting Blood Test for Insulin Resistance and Prediabetes (2013) (75)
Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study (2009) (75)
GLP-1 and Glucose Tolerance After Sleeve Gastrectomy in Morbidly Obese Subjects With Type 2 Diabetes (2014) (75)
Is insulin resistance the cause of the metabolic syndrome? (2006) (75)
Interaction of carnitine with insulin-stimulated glucose metabolism in humans. (1988) (75)
Anti‐CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease (2001) (74)
Effects of age and physical fitness on microcirculatory function. (2004) (74)
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. (2006) (74)
Renal effects of insulin in man. (1997) (74)
Genetic Variants Associated With Glycine Metabolism and Their Role in Insulin Sensitivity and Type 2 Diabetes (2013) (74)
Ultrasonic myocardial textural analysis in subclinical hypothyroidism. (2000) (74)
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. (2006) (73)
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes (2002) (73)
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study (2011) (73)
Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists. (2010) (73)
Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease. (2017) (72)
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. (2003) (72)
Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. (2007) (72)
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. (2006) (71)
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents. (2018) (71)
Hepatic glucose production in insulin-resistant states. (1989) (70)
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics. (1984) (70)
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. (1997) (69)
α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance (2016) (69)
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. (2006) (69)
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. (2008) (69)
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration. (2005) (69)
Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion (2015) (69)
Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study (2013) (68)
β-Cell Function, Incretin Effect, and Incretin Hormones in Obese Youth Along the Span of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes (2014) (68)
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. (2003) (68)
Thyroid autoimmunity and dysfunction associated with type I interferon therapy (2004) (68)
PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION (2018) (67)
Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures. (2005) (66)
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man (1999) (65)
Insulin resistance of stress: sites and mechanisms. (1993) (64)
Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man. (1993) (64)
Influence of long-term diabetes on liver glycogen metabolism in the rat. (1990) (64)
Insulin sensitivity and hypertension. (1990) (63)
Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. (1998) (61)
Effect of Insulin on Systemic and Renal Handling of Albumin in Nondiabetic and NIDDM Subjects (1997) (61)
Iodine-131 Given for Therapeutic Purposes Modulates Differently Interferon-γ-Inducible α-Chemokine CXCL10 Serum Levels in Patients with Active Graves’ Disease or Toxic Nodular Goiter (2007) (61)
A model for glucose control of insulin secretion during 24 h of free living. (2001) (61)
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog. (1985) (61)
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) (61)
Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. (1987) (61)
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. (2013) (60)
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis (2008) (60)
Glycogen depletion during prolonged exercise: influence of glucose, fructose, or placebo. (1985) (60)
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. (2008) (59)
Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. (1997) (59)
Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. (2005) (59)
Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. (1982) (59)
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. (2002) (59)
Sodium‐glucose co‐transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes (2017) (58)
Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes (2008) (58)
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. (2008) (58)
The metabolic syndrome. (2005) (58)
The metabolic consequences of long-term human obesity. (1988) (57)
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone. (2011) (57)
Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes (2007) (56)
High blood pressure and insulin resistance: influence of ethnic background (1991) (56)
Reply to Comment on: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 43:31–39 (2004) (56)
Improvement in Insulin Sensitivity and Β-Cell Function Following Ileal Interposition with Sleeve Gastrectomy in Type 2 Diabetic Patients: Potential Mechanisms (2011) (55)
Definition of intervention points in prediabetes. (2014) (55)
Effect of ischaemia on sensory potentials of normal subjects of different ages (1973) (54)
Polymorphisms in the hANP (Human Atrial Natriuretic Peptide) Gene, Albuminuria, and Hypertension (2001) (54)
Adiponectin and left ventricular structure and function in healthy adults. (2008) (54)
Insulin action and non-esterified fatty acids (1997) (54)
Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy (1993) (53)
Syndrome X. (1993) (53)
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects (1996) (52)
Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. (1994) (52)
Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2017) (52)
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. (2008) (51)
Visceral fat and beta cell function in non-diabetic humans (2005) (51)
Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. (1985) (51)
Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non‐insulin‐dependent diabetes (1997) (51)
Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? (1993) (50)
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes (2002) (50)
Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. (2016) (50)
Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis (2009) (50)
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients (1998) (50)
Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles (2008) (50)
Oxidative and non-oxidative glucose metabolism in non-obese Type 2 (non-insulin-dependent) diabetic patients (1988) (50)
A compartmental model to quantitate in vivo glucose transport in the human forearm. (1989) (49)
The haemodynamics of obesity: a theoretical analysis (1992) (49)
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver (2004) (49)
Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome? (2011) (47)
Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. (2007) (47)
Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes (2015) (47)
Insulin and the Renin‐Angiotensin-Aldosterone System: Influence of ACE Inhibition (1994) (46)
Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin (2009) (46)
Renal Glucose Handling Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes (2013) (46)
Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression (2007) (46)
Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis. (1999) (46)
Effect of Chronic ACE Inhibition on Glucose Tolerance and Insulin Sensitivity in Hypertensive Type 2 Diabetic Patients (1992) (46)
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition (2015) (45)
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus (2008) (45)
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects (2000) (45)
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. (2003) (45)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (45)
7 Insulin action and substrate competition (1993) (44)
Coronary Atherosclerosis and Alcohol Consumption: Angiographic and Mortality Data (2006) (44)
Metabolic and thermogenic effects of lactate infusion in humans. (1993) (44)
18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study. (2006) (44)
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. (2005) (44)
Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men (2011) (43)
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ. (2014) (43)
Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic (2014) (43)
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era? (2020) (43)
Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. (1979) (43)
Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk (2017) (42)
Influence of Hyperinsulinemia and Insulin Resistance on In Vivo β-Cell Function (2011) (42)
Mechanisms through which a small protein and lipid preload improves glucose tolerance (2015) (42)
Influence of Long-Term Diabetes on Renal Glycogen Metabolism in the Rat (2001) (42)
Effect of free fatty acids on blood amino acid levels in human. (1986) (42)
Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study (2009) (42)
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes (2019) (42)
A novel surrogate index for hepatic insulin resistance (2011) (42)
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery (2009) (41)
Insulin Sensitivity and Carotid Intima-Media Thickness: Relationship Between Insulin Sensitivity and Cardiovascular Risk Study (2013) (40)
LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES (1978) (40)
A Novel Test for IGT Utilizing Metabolite Markers of Glucose Tolerance (2014) (40)
Renal Glucose Handling (2013) (40)
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state (2007) (40)
Energy metabolism of surgical patients in the early postoperative period: a reappraisal. (1988) (39)
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. (2012) (39)
In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance. (1996) (39)
Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes (2017) (38)
Metabolic Markers of Stress‐Induced Myocardial Ischemia (1991) (38)
Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index (2018) (38)
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter. (2007) (38)
Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration. (2001) (38)
Effects of acute hypercarnitinemia during increased fatty substrate oxidation in man. (1993) (37)
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (2005) (37)
Skin Vasodilator Function and Vasomotion in Patients with Morbid Obesity: Effects of Gastric Bypass Surgery (2011) (37)
Amino acid and glucose metabolism in the postabsorptive state and following amino acid ingestion in the dog. (1986) (37)
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. (2014) (37)
Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk (2008) (37)
Energy expenditure and gas exchange measurements in postoperative patients: Thermodilution versus indirect calorimetry (1992) (36)
Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes (2013) (36)
Insulin action and substrate competition. (1993) (36)
Mechanisms linking empagliflozin to cardiovascular and renal protection. (2017) (36)
Adipose tissue and skeletal muscle insulin-mediated glucose uptake in insulin resistance: role of blood flow and diabetes. (2018) (36)
Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14). (2009) (36)
Learning From Glycosuria (2011) (36)
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. (2004) (36)
In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. (2002) (35)
Insulin decreases circulating vitamin E levels in humans. (1996) (35)
Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes (2018) (35)
Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. (1982) (34)
Metabolic interactions of amino acids and glucose in healthy humans (1988) (34)
A soluble PC-1 circulates in human plasma: relationship with insulin resistance and associated abnormalities. (1999) (34)
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4. (2007) (34)
Characterization of a reversed-phase high-performance liquid chromatographic system for the determination of blood amino acids. (1990) (33)
Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion (2013) (33)
Metabolic Abnormalities of Hypertension A Lesson in Complexity (1991) (33)
Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study (2016) (33)
Insulin kinetics after portal and peripheral injection of [125I] insulin: II. Experiments in the intact dog. (1976) (33)
Defective regulation and action of atrial natriuretic peptide in type 2 diabetes. (2002) (33)
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin. (2005) (32)
Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans. (1989) (32)
Insulin resistance and normal thyroid hormone levels: prospective study and metabolomic analysis. (2017) (31)
Of Microbes and Men (2015) (31)
Liver uptake of free fatty acids in vivo in humans as determined with 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid and PET (2003) (31)
Long‐term interferon &bgr;‐1b therapy for MS: Is routine thyroid assessment always useful? (2000) (31)
Effects of different LDL particles on inflammatory molecules in human mesangial cells (2008) (31)
Endothelial dysfunction in type 2 diabetes (2012) (31)
Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia. (2004) (30)
Schwartz-Jampel syndrome with autosomal-dominant inheritance. (1982) (30)
Fasting‐based Estimates of Insulin Sensitivity in Overweight and Obesity: A Critical Appraisal (2006) (29)
Familial paroxysmal exercise-induced dyskinesia and benign epilepsy: a clinical and neurophysiological study of an uncommon disorder (2000) (29)
Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension (2000) (29)
High‐density lipoprotein‐cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive (2011) (29)
Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia. (2007) (29)
Sodium elevates the plasma glucose response to glucose ingestion in man. (1982) (29)
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. (2009) (29)
Effect of PPAR-γ Activation and Inhibition on Glucose-Stimulated Insulin Release in INS-1e Cells (2004) (28)
Insulin actions in vivo: glucose metabolism (2004) (28)
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. (2021) (28)
The threshold shift paradigm of obesity: evidence from surgically induced weight loss. (2014) (27)
Metabolic characteristics of prehypertension: role of classification criteria and gender (2009) (27)
Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study (2021) (27)
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. (2009) (27)
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects. (1996) (27)
Menopause, insulin resistance, and risk factors for cardiovascular disease (2006) (27)
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse (2004) (26)
Human Mitochondrial Transcription Factor A Reduction and Mitochondrial Dysfunction in Hashimoto’s Hypothyroid Myopathy (2002) (26)
The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies (1999) (26)
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests. (2005) (26)
Insulin and blood pressure: possible role of hemodynamics. (1992) (26)
Risk Factors for Spontaneously Self-Reported Postprandial Hypoglycemia After Bariatric Surgery. (2016) (26)
Measurement of glucose-induced insulin delivery rate in man by deconvolution analysis. (1977) (26)
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. (2005) (26)
Reciprocal association between insulin sensitivity and the haematocrit in man (1997) (26)
CD38 autoimmunity: Recent advances and relevance to human diabetes (2004) (26)
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism (2002) (26)
High Serum Levels of CXC (CXCL10) and CC (CCL2) Chemokines in Untreated Essential Hypertension (2012) (25)
Response to Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114 (2016) (25)
Internal biliary diversion improves glucose tolerance in the rat. (1985) (25)
Glucoregulatory function of thyroid hormones: role of pancreatic hormones. (1989) (25)
Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow‐up (2018) (25)
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. (2010) (25)
Influence of endogenous NEFA on beta cell function in humans (2015) (25)
Sodium-glucose transporter-2 inhibition as an antidiabetic therapy. (2010) (24)
Is insulin resistance atherogenic? A review of the evidence. (2006) (24)
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. (2012) (24)
Insulin sensitivity in familial hypercholesterolemia. (1993) (24)
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. (2015) (24)
CXCL10 ( a ) and CCL2 ( b ) chemokines in systemic sclerosis—a longitudinal study (2007) (23)
Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog. (1981) (23)
Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery. (2017) (23)
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. (2013) (23)
Branched‐chain amino acids and amyotrophic lateral sclerosis (1993) (23)
Leptin pulsatility in formerly obese women (2005) (23)
Impaired insulin degradation in a patient with insulin resistance and acanthosis nigricans. (1982) (23)
Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes (2006) (23)
The effects of taurine on pharmacologically induced myotonia (1989) (23)
High glucose and homocysteine synergistically affect the metalloproteinases–tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts (2006) (23)
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals (2009) (22)
AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus (2006) (22)
A Strategy for Arterial Risk Assessment and Management in Type 2 (Non‐insulin‐dependent) Diabetes Mellitus (1997) (22)
Association Analysis of 29,956 Individuals Confirms That a Low-Frequency Variant at CCND2 Halves the Risk of Type 2 Diabetes by Enhancing Insulin Secretion (2015) (22)
Mechanisms of Sodium–Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics (2020) (22)
Insulin kinetics after portal and peripheral injection of [125I] insulin. I. Data analysis and modeling. (1976) (22)
Potassium as a link between insulin and the renin-angiotensin-aldosterone system. (1992) (22)
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (2006) (21)
Impact of mild to moderate reductions of glomerular filtration rate on coronary artery disease severity. (2014) (21)
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. (2005) (21)
Modeling glucose metabolism in man: theory and practice. (1990) (21)
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial (2019) (21)
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study (2020) (21)
Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy. (2013) (21)
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes (2016) (21)
Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients (2008) (21)
microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function (2018) (21)
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease. (2011) (20)
Insulin secretion: movement at all levels. (2002) (20)
Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence (2017) (20)
Hypertension: a metabolic disorder? (1989) (20)
Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts (2013) (20)
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. (2011) (20)
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype. (2009) (20)
Impact of Associated Conditions on Glycemic Control of NIDDM Patients (1992) (20)
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2017) (20)
Effects of acute alpha 2-blockade on insulin action and secretion in humans. (1998) (20)
The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects. (2012) (19)
The association of essential hypertension and diabetes. (1989) (19)
Renal hemodynamics and fatty acid uptake: effects of obesity and weight loss. (2019) (19)
A case of concomitant amyotrophic lateral sclerosis and HIV infection (2002) (19)
Pathophysiology, Prevention and Management of Chronic Kidney Disease in the Hypertensive Patient With Diabetes Mellitus (2011) (19)
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). (1997) (19)
Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: A positron emission tomography study (2020) (19)
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort (2021) (19)
Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans. (1999) (19)
Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair (2007) (18)
Insulin resistance: a universal finding in diabetic states. (1981) (18)
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. (2012) (18)
Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa (1990) (18)
Quantification of liver perfusion with [(15)O]H(2)O-PET and its relationship with glucose metabolism and substrate levels. (2008) (18)
Sibutramine lost and found (2002) (18)
The islet in type 2 diabetes: back to center stage. (2001) (18)
Glycogen turnover during refeeding in the postabsorptive dog: implications for the estimation of glycogen formation using tracer methods. (1994) (18)
Splanchnic Amino Acid and Glucose Metabolism During Amino Acid Infusion in Dogs (1988) (18)
Insulin kinetics and glucose-induced insulin delivery in chronically dialyzed subjects: acute effects of dialysis. (1979) (18)
Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. (2005) (18)
A tale of two cousins: type 1 and type 2 diabetes. (2005) (17)
Differences in β‐cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role? (2017) (17)
Insulin resistance and hypertension: connections with sodium metabolism. (1993) (17)
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy. (2012) (17)
Obesity and carotid artery remodeling (2015) (17)
Metabolic effects of glucose-insulin infusions: myocardium and whole body (2001) (17)
In ﬂ uence of Hyperinsulinemia and Insulin Resistance on In Vivo b -Cell Function Their Role in Human b -Cell Dysfunction (2011) (17)
Evidence for suppressor cell activity associated with depression of contact sensitivity in Pseudomonas aeruginosa infected mice. (1976) (17)
Relation Between Left Ventricular Midwall Function and Coronary Vasodilator Capacity in Arterial Hypertension (2003) (17)
Hyperinsulinemia in patients with hypercholesterolemia. (1992) (17)
Influence of gestational diabetes on the long-term control of glucose tolerance (2007) (17)
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia. (2006) (17)
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine. (2014) (16)
On linearity of insulin kinetics. (1986) (16)
Role of Thromboxane A2 Receptor on the Effects of Oxidized LDL on Microvascular Endothelium Nitric Oxide, Endothelin‐1, and IL‐6 Production (2008) (16)
Hepatitis C virus infection and type 2 diabetes. (2013) (16)
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes (2018) (16)
Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets. (2002) (16)
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial (2020) (16)
Association between polymorphisms of the Atrial Natriuretic Peptide gene and proteinuria: a population-based study (2003) (16)
Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells. (2004) (16)
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus (2003) (16)
Splanchnic amino acid and glucose metabolism during amino acid infusion in dogs. (1988) (16)
Marrow aplasia following colchicine treatment for gouty arthritis. (1984) (15)
CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis. (2009) (15)
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation (2011) (15)
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment (2021) (15)
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence (2021) (15)
Reduced Left Ventricular Functional Reserve in Hypertensive Patients With Preserved Function at Rest (2005) (15)
GLUCOSE-TRANSPORT IN HUMAN SKELETAL-MUSCLE - THE INVIVO RESPONSE TO INSULIN (1993) (15)
Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis. (2002) (15)
Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht Study (2017) (15)
Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients (2010) (15)
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. (2013) (15)
Impact of Postprandial Hypoglycemia on Weight Loss After Bariatric Surgery (2020) (15)
Insulin receptor autophosphorylation and kinase activity in streptozotocin diabetic rats. Effect of a short fast. (1986) (15)
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity (2013) (15)
Insulin resistance and hypertension: studies in transgenic hypertensive TGR(mREN-2)27 rats. (1994) (15)
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response. (2017) (15)
Insulin and blood pressure: connected on a circumference? (2005) (15)
Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes (2004) (14)
Chapter 35 – Regulation of Intermediary Metabolism During Fasting and Feeding (2015) (14)
Differential Impact of Weight Loss and Glycemic Control on Inflammasome Signaling (2020) (14)
Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß‐cell function in non‐diabetic, morbidly obese patients (2017) (14)
Diabetes research investment in the European Union (2006) (14)
Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes (2021) (14)
Comprehensive neurophysiological evaluation of lead-exposed workers (1983) (14)
Metabolic effects of muraglitazar in type 2 diabetic subjects (2011) (14)
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves’ ophthalmopathy fibroblasts and preadipocytes (2012) (14)
Inadvertent catheterization of the internal thoracic vein mimicking pulmonary embolism: a case report. (1988) (14)
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine. (2013) (14)
Experimental evaluation of the effects of pravastatin on electrophysiological parameters of rat skeletal muscle. (1992) (14)
Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia. (2010) (14)
Common genetic variants highlight the role of insulin resistance and body fat 1 distribution in type 2 diabetes , independently of obesity (2015) (14)
Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man. (2019) (14)
CLINICAL Increase of interferon- g inducible a chemokine CXCL10 but not b chemokine CCL2 serum levels in chronic autoimmune thyroiditis (2005) (13)
Acute vascular events and electrolytes variations in elderly patients. (2006) (13)
Effects of glucose tolerance on the changes provoked by glucose ingestion in microvascular function (2008) (13)
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes (2020) (13)
The metabolic syndrome (2005) (13)
Kinetic analysis of thyroid hormone action on glucose metabolism in man. (1995) (13)
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension (2008) (13)
Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension. (2001) (13)
Coronary artery disease and arterial hypertension: clinical, angiographic and follow‐up data (2000) (13)
Euglycemic Clamp Insulin Sensitivity and Longitudinal Systolic Blood Pressure: Role of Sex (2013) (12)
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects (2011) (12)
The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis. (1979) (12)
Familial paroxysmal exercise‐induced dyskinesia, epilepsy, and mental retardation in a family with autosomal dominant inheritance (2001) (12)
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes (2018) (12)
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. (2010) (12)
The past 10 years—new hormones, new functions, new endocrine organs (2015) (12)
Diabetes and high blood pressure (1990) (12)
Insulin Resistance in Humans Is Associated With Increased Plasma 12-Hydroxylated Bile Acids (2013) (12)
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia (2005) (11)
Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study (2018) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Sweetened beverages intake, hyperuricemia and metabolic syndrome: the Mexico City Diabetes Study. (2013) (11)
Renovascular hypertension and insulin sensitivity (1996) (11)
Insulin Resistance and Blood Pressure (1999) (11)
Diabetes Research and Care Through the Ages (2017) (10)
Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibition (2018) (10)
Metabolic effects of antihypertensive treatment: long live the debate. (2003) (10)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (10)
Hyperinsulinemia, Insulin Resistance, and Blood Pressure (1992) (10)
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: a ten-year follow-up study. (2021) (10)
A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture (2021) (10)
Energy Balance After Sodium Glucose Cotransporter 2 ( SGLT 2 ) Inhibition (2015) (10)
SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise. (2020) (10)
Triglyceride‐rich very low‐density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents (2018) (10)
Tissue-Specific Alteration of Metabolic Pathways Influences Glycemic Regulation (2019) (9)
Effect of levothyroxine on myocardial contractility and structure in subclinical hypothyroidism (2001) (9)
[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders]. (2005) (9)
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia. (1996) (9)
Effects of Insulin on the Kidney and the Cardiovascular System (2000) (9)
The amino acid response to a mixed meal in patients with type 2 diabetes: effect of sitagliptin treatment (2014) (9)
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals. (2018) (9)
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study (2019) (9)
Slope of change in HbA1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes (2018) (9)
Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance (2015) (9)
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery (2020) (9)
Anti-CD38 Autoimmunity in Children with Newly Diagnosed Type 1 Diabetes Mellitus (2005) (9)
Conventional electromyography in myotonic dystrophy. (1976) (9)
Renal handling of insulin in man. (1984) (9)
The ivsulin resistance syndrome (1992) (9)
Metabolic Effects of Combined Antihypertensive Treatment in Patients With Essential Hypertension (2002) (8)
Glucose uptake saturation explains glucose kinetics profiles measured by different tests. (2016) (8)
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery (2018) (8)
Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study (2019) (8)
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alpha. (2012) (8)
Influence of combined intravenous and oral glucose administration on splanchnic glucose uptake in man. (1990) (8)
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis (2008) (8)
Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport (2020) (8)
Metformin and Heart Failure: Innocent Until Proven Guilty (2006) (8)
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms (2021) (8)
Cardiovascular safety of insulin: Between real‐world data and reality (2017) (8)
Brain substrate metabolism and ß‐cell function in humans: A positron emission tomography study (2020) (7)
β-Cell Function in Severely Obese Type 2 Diabetic Patients (2007) (7)
HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: a Multi-Center Cohort Study. (2021) (7)
Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea (2020) (7)
New American Diabetes Association (ADA)/European Association for the Study of diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: placing them into a practicing physician's perspective. (2020) (7)
GLP-1 response to sequential mixed meals: influence of insulin resistance. (2017) (7)
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange (1997) (7)
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin (2012) (7)
Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk? (2015) (7)
Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomy. (2008) (7)
Therapy: SGLT inhibition in T1DM — definite benefit with manageable risk (2017) (7)
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease (2022) (7)
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes. (2020) (6)
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients. (1992) (6)
Acute respiratory distress syndrome in an adult patient with a myelodysplastic disorder. (1983) (6)
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowroński et al. (2006) (6)
Effects of physiological plasma insulin levels on glucose turnover parameters in familial hypercholesterolemia. (1993) (6)
LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanine. (2007) (6)
Linear and Nonlinear Properties of Heart Rate Variability: Influence of Obesity (1999) (6)
Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin. (2000) (6)
Normal insulin sensitivity in lean offspring of obese parents. (2004) (6)
β‐Cell mass and function in human type 2 diabetes (2015) (6)
Multiple P 2 X receptors are involved in the modulation of apoptosis in human mesangial cells : evidence for a role of P 2 X 4 (2007) (6)
Radioimmunoassay of labeled and unlabeled insulin mixtures. (1976) (6)
Insulin resistance and cardiovascular outcomes in the ORIGIN trial (2018) (6)
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. (2019) (6)
Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? (2021) (6)
Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes. (2022) (5)
Response to Comment on: Ferrannini. Learning From Glycosuria. Diabetes 2011;60:695–696 (2011) (5)
gamma-Glutamyltransferase concentrations and obstructive sleep apnea syndrome: effect of bariatric surgery (2016) (5)
Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance. (2021) (5)
A model for assessing insulin secretion and its control under free-living conditions. (2001) (5)
Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertension (2003) (5)
Anti-In fl ammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes (2011) (5)
Quantification of d-mannose in plasma: Development and validation of a reliable and accurate HPLC-MS-MS method. (2019) (5)
Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension. (2003) (5)
Pathophysiology of Prediabetes: Role of Lipotoxicity? (2014) (5)
Diabetes and hypertension: the scope of the problem. (1996) (5)
Insulin resistance, insulin deficiency and the pathogenesis of diabetes mellitus. (1986) (5)
Editorial: Novel Factors in the Regulation of β-Cell Function (2004) (5)
Insulin resistance versus β-cell dysfunction in the pathogenesis of type 2 diabetes (2009) (5)
Hormone‐substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active‐controlled DURATION‐8 study (2019) (5)
Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization. (2020) (4)
Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor. (1991) (4)
Triglyceride-Induced Diabetes Associated Wi t h Familial Lipoprotein Lipase Defic i e n c y (1999) (4)
Impact of a mild decrease in fasting plasma glucose on β-cell function in healthy subjects and patients with type 2 diabetes. (2016) (4)
Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution. (2015) (4)
Delta-aminolevulinic acid dehydratase and zinc protoporphyrin in very low lead-exposed pets: a community study. (1996) (4)
Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes. (2020) (4)
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans (2022) (4)
Changes in Prandial Glucagon Levels after 2-year Treatment with Vildagliptin or Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy Short title: Glucagon after vildagliptin versus glimepiride (2010) (4)
Canagliflozin, a Sodium Glucose co-transporter 2 (SGLT2) inhibitor, improves indices of β-cell function in patients with type 2 diabetes on metformin plus sulphonylurea (2013) (4)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (4)
Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis (2020) (4)
Regulation of insulin production: in search of therapeutic targets. Proceedings of the 3rd Servier-IGIS Symposium. St Jean Cap Ferrrat, France, 21-24 March 2002. (2002) (4)
Treatment of obesity: bariatric surgery (2015) (4)
The Kidney and Hypertension in Diabetes Mellitus (1998) (4)
Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108–1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115–1122 (2016) (4)
Some metabolic aspects of essential hypertension and its treatment. (1993) (4)
Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2018) (4)
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study. (2021) (4)
Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes (2013) (4)
The insulin resistance syndrome. (1999) (3)
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 2016;39:1186–1201 (2017) (3)
Association between expression of insulin resistance (IR) related genes and breast cancer outcome (2007) (3)
Distribution of 51Cr-labeled lymph node cells in Pseudomonas aeruginosa-infected mice. (1977) (3)
The Role of (cid:1) -Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery (2011) (3)
Separate impact of obesity and glucose tolerance on incretin effect in humans (2007) (3)
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes (2020) (3)
Effects of Short and Prolonged Mild Intracellular Nitric Oxide Manipulations on Various Aspects of Insulin Secretion in INS-1E β-Cells (2012) (3)
SGLT 2 and SGLT 1 renal expression in patients with type 2 diabetes (2017) (3)
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity (2020) (3)
[Unusual neuromuscular pathology. I. Electromyographic and histoenzymatic findings in the muscles in a subject with "continuous muscular activity syndrome" ("neuromyotonia")]. (1970) (3)
Syddansk Universitet Association analysis of 29 , 956 individuals confirms that a low-frequency variant at CCND 2 halves the risk of type 2 diabetes by enhancing insulin secretion (2015) (3)
35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
[Electroclinical evaluation of the anti-epileptic action of taurine]. (1977) (3)
Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes (2018) (3)
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS). (2022) (3)
Insulin secretion and impaired glucose tolerance. Reply to Jenkins AB, Campbell LV [letter] (2010) (3)
Gastrointestinal control of glycaemia (1996) (3)
Nuclear pyknosis in neuroglia cells of normal mammals (1967) (3)
Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study (2022) (3)
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells (2008) (3)
Effects of acute a2-blockade on insulin action and secretion in humans (1998) (3)
Tirzepatide as an insulin sensitizer. (2021) (3)
Abnormalities of Carbohydrate Metabolism (1989) (3)
Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646 (2021) (2)
Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride (2009) (2)
Insulin sensitivity in cardiological syndrome X (1996) (2)
Of mighty mice and diabetic men: animal models of islet dysfunction (2007) (2)
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program (2022) (2)
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study (2022) (2)
Erratum: Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study (2010) (2)
Hypertension and Insulin Resistance (1997) (2)
Identification of novel insulin resistance metabolites in a non-diabetic population by global biochemical profiling (2009) (2)
Title: Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline Short Title: Guidelines for Patients at Metabolic Risk (2008) (2)
Lipoprotein profile in subclinical hypothyroidism: a randomized placebo-controlled study (2001) (2)
Clinical and metabolic effects of long-term treatment with 25(OH)D3 in hemodialysis. (1985) (2)
A Multi-Region Distributed Model of Glucose Kinetics in the Human Myocardium (1994) (2)
Beneficial Effects of RYGB on ß-Cell Function and Hepatic and Peripheral Insulin Sensitivity Are Maintained Seven Years after Surgery in Both Diabetic and Nondiabetic Subjects (2018) (2)
A cross-sectional analysis of the RISC Study (2013) (2)
METHYLGUANIDINE AND INSULIN RESPONSE IN PATIENTS ON MAINTENANCE HÆMODIALYSIS (1976) (2)
Postpericardiectomy syndrome in a patient with radiation-induced pericardial effusion. (1983) (2)
Genetic variation in PNPLA 3 ( adiponutrin ) confers sensitivity to weight loss – induced decrease in liver fat in humans 1 – 3 (2011) (2)
Rosiglitazone and lipid metabolism (2004) (2)
Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway (2022) (2)
Model Analysis of β-Cell Function in First-Degree Relatives of Type 2 Diabetics and Its Relation to Insulin Resistance (2002) (1)
INSULIN KINETICS AFTER PORTAL AND PERIPHERAL INJECTION OF [INSULIN[I-125] .1. DATA-ANALYSIS AND MODELING (1976) (1)
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk (2020) (1)
Keep an eye on diabetes (2006) (1)
EFFECTS OF 6 WEEKS OF TREATMENT WITH DAPAGLIFLOZIN, A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, ON MYOCARDIAL FUNCTION AND METABOLISM IN TYPE 2 DIABETES PATIENTS: A RANDOMIZED PLACEBO-CONTROLLED STUDY (2020) (1)
Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes (2022) (1)
The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes (2022) (1)
Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects (2021) (1)
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humans (2022) (1)
Concerns of an Editor for the Diabetologist (2004) (1)
Impact of treatment on islet function in type 2 diabetes. (2004) (1)
Sites and mechanism of insulin (I)-mediated potassium (K) metabolism in man (1979) (1)
Effect of essential hypertension on endothelial function in type 2 diabetic patients (2001) (1)
Response to Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638–1642 (2016) (1)
Visceral Adiposity as the Main Determinant of Carotid Stiffness in a Healthy Population With a Wide BMI and Age Range: Evidence From an Echo-Tracking Approach (2007) (1)
Fixed‐ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß‐cell function in people with type 2 diabetes (2022) (1)
A vascular protective concept in hypertension and heart failure. (1994) (1)
Th-W56:4 High glucose and homocysteine synergistically affect MMP-TIMP, but not TGFbeta pattern in human fibroblasts (2006) (1)
Endothelial dysfunction in patients with subclinical hypothyroidism: Role of systemic inflammation (2004) (1)
Ventriculo-arterial coupling in a population with a wide BMI and age range: a wave intensity analysis study (2007) (1)
Synergistic interaction between exercise and insulin in stimulating glucose uptake in man (1979) (1)
Abstract 46: Bile Acid Synthesis and 12-Hydroxylation are Increased, and Bile Acid Transport is Impaired in Human Obesity (2016) (1)
EFFECTS OF INSULIN ON THE CARDIOVASCULAR SYSTEM AND THE KIDNEY (2004) (1)
Pre-diabetes: to treat or not to treat? (2003) (1)
[Bariatric surgery as a treatment of type 2 diabetes]. (2011) (1)
Glycated haemoglobin in nondiabetic pregnancy: Relation to neonatal weight and pregnancy outcome (1996) (1)
261-OR: Dorzagliatin, a Dual-Acting Glucokinase Activator. Improves Insulin Secretion and Glucose Sensitivity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) (2022) (1)
Beta (CCL2) and alpha (CXCL10) chemokines modulation by cytokines and by peroxisome proliferator-activated receptor-alpha agonists in Graves' ophthalmopathy (2012) (1)
[Muscular electrophysiological and histochemical findings in a case of botulinic poisoning]. (1971) (1)
MS09.2 Empagliflozin Reduces Mortality In Patients With Type 2 Diabetes and A History of Left Ventricular Hypertrophy: A Sub-analysis of the EMPA-REG OUTCOME Trial (2018) (1)
Obesity : the case for medical intervention (1995) (1)
Vaccinations and Type 1 Diabetes (2015) (1)
Relationships between Glucose Clearance during an OGTT and a Euglycemic Clamp (2010) (1)
Syndrome x a primary metabolic disease (1989) (1)
Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study. (2020) (1)
Coronary atherosclerosis in non-insulin-dependent diabetes (NIDDM): Risk factors (RF) and impact on mortality. (1996) (1)
Viral Infections and Type 1 Diabetes (2015) (1)
Intravenous glucose tolerance and maintenance haemodialysis. (1977) (1)
European Obesity Summit (EOS) – Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1 – 4, 2016: Abstracts (2016) (1)
Sleeping oxygen saturation, rapid eye movement sleep, and the adaptation of postprandial metabolic function in insulin sensitive and resistant individuals without diabetes (2018) (1)
Of insulin resistance and normalcy (1992) (1)
Sympathetic activation and muscle spindle. (1987) (1)
Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution (2019) (1)
Loss of the incretin effect in type 2 diabetes: a systematic review and meta-analysis. (2022) (1)
Th-P15:152 LDL resistance to copper-induced oxidation: Effect of LDL lipid composition (2006) (0)
4.P.55 Troglitazone, a novel antidiabetic agent, reduces oxidation of low density lipoprotein and E-selectin plasma concentration in NIDDM patients (1997) (0)
Hyperinsulinemia and hyperdynamic circulation are detectable in prehypertensive subjects in the absence of cardiovascular remodelling: new insight from a wave intensity analysis approach (2009) (0)
Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843–851 (2021) (0)
Interferon Beta induces IL-6 release but not apoptosis in primary cultures of human thyrocytes (2004) (0)
Imatinib Therapy for Patients with Recent-Onset Type 1 Diabetes: A Randomised Blinded Phase 2 Trial (2021) (0)
Effects of angiotensin-converting enzyme inhibition on carbohydrate metabolism and insulin sensitivity in hypertensive patients (1991) (0)
Myocardial inotropic function is related to insulin sensitivity in type 2 diabetic patients (2001) (0)
BRIEF REPORT Recombinant Human Thyrotropin Reduces Endothelium-Dependent Vasodilation in Patients Monitored for Differentiated Thyroid Carcinoma (2006) (0)
Increased sympathetic drive to the cardiovascular system in middle-aged obese women: new evidence from a wave intensity approach (2004) (0)
Pattern of expression of inflammatory markers in adipose tissue of untreated patients with essential hypertension (2009) (0)
Dyslipidaemia versus endothelial dysfunction: which is more important in the development of vascular disease? (2003) (0)
Glucose uptake transition from the fasted to the hyperglycemic hyperinsulinemic state in different body organs by [F-18] FDG-PET (2006) (0)
In healthy untrained subjects, bouts of moderate-vigorous physical activity are associated with increase in LV mass and decrease in plasma levels of adiponectin and leptin (2011) (0)
GAMMA-GLUTAMYLTRANSFERASE AND ADIPONECTIN AS DETERMINANTS OF PRESENCE AND ACOUSTIC PROPERTIES OF EARLY CAROTID PLAQUES IN NORMAL SUBJECTS: PP.19.112 (2011) (0)
Edinburgh Research Explorer Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes (2018) (0)
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4. (2021) (0)
Serum α-Chemokine CXCL10 and β-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia (2012) (0)
Studies of the association between alcohol consumption and coronary atherosclerosis (2006) (0)
CHARACTERIZATION OF THE BIOLOGICAL MECHANISMS OF EMPAGLIFLOZIN THROUGH LARGE-SCALE PROTEOMICS (2018) (0)
Progression of Beta Cell Dysfunction in Subjects at Risk for Type 1 Diabetes (2010) (0)
Consensus Reports (2011) (0)
MS494 ROSUVASTATIN MODULATES GLUCOSE AND FFA-INDUCED PRO-FIBROTIC PATTERNS IN HUMAN MESANGIAL CELLS (2010) (0)
Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients. (2023) (0)
Visceral adiposity as main determinant of arterial stiffness in a normotensive population at low cardiovascular risk: evidence by from a new echo-tracking approach (2007) (0)
Impaired glucose tolerance exacerbates the abnormal myocardial metabolic response to pacing in subjects with dilated cardiomyopathy (2008) (0)
Physiological predictors of changes in glucose tolerance in a non-diabetic population: the RISC Study (2010) (0)
Pattern of expression of inflammatory markers in adipose tissue of neive hypertensive subjects (2009) (0)
An average daily physical activity is an independent determinant of local carotid stiffness and myocardial performance (2011) (0)
A Vascular Protective Concept in Hypertension and (1994) (0)
Effective blood pressure treatment improves LDL‐cholesterol susceptibility to oxidation in patients with essential hypertension (2001) (0)
LUNG FLUXES OF LACTATE, PYRUVATE AND OTHER ENERGY BLOOD-BORNE SUBSTRATES DURING SURGICAL STRESS (1995) (0)
Relation of birth weight to markers of feto-maternal β-cell function (1997) (0)
Suppurative spondylitis with pelvic abscess: localization by 67-gallium scanning. (1975) (0)
Insulin resistance and glucose tolerance are not related to left ventricular mass in humans. (1999) (0)
Closing remarks (1999) (0)
Book Review Hypertension and Co-existing Disease By Francisco Leyva and Andrew Coats. 240 pp., illustrated. Malden, Mass., Blackwell Science, 2000. $99. 0-632-05073-X (2000) (0)
Short-term and longer-term metabolic effects of biliopancreatic diversion (BPD) in non-morbidly obese patients with type 2 diabetes mellitus (2011) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
1827-P: Higher Glucagon-Like Peptide-1 Response and Lower Beta-Cell Glucose Sensitivity Are Associated with Increased Glycemic Variability among Individuals with Prediabetes (2019) (0)
Effect of glucose-insulin-potassium infusion (GIK) on stress-induced myocardial ischaemia (2008) (0)
60 Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis (2004) (0)
Effect of insulin on skeletal muscle metabolism in essential hypertension (1990) (0)
chorego – stanowisko American Diabetes Association ( ADA ) i European Association for the Study of Diabetes ( EASD ) (2016) (0)
Impaired coronary vasodilator capacity and exercise-induced myocardial ischemia in hypertensive patients are related to pulse pressure (2002) (0)
Measures of central obesity are corelated to indices of local arterial stiffness in a population with a wide BMI and age range (2007) (0)
Effect of hyperinsulinaemia on gluconeogenesis in non-diabetic subjects and in Type 2 diabetic patients. (2000) (0)
EASD News Section September 2004 (2004) (0)
Increased myocardial uptake of lipids and impaired utilization of lactate and pyruvate in patients with mild to moderate high blood pressure (1992) (0)
945 Waist circumference is an independent predictor of left ventricular mass in normotensive obese subjects without comorbidities (2005) (0)
The assessment of glucose appearance rate and hepatic glucose uptake by [18F]fluorodeoxyglucose : validation against 6,6-2H-glucose (2005) (0)
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE (2023) (0)
metabolism: a non-steady-state approach Dose-response characteristics of insulin action on glucose (2013) (0)
419 Early subclinical left ventricular dysfunction is related to increased blood pressure in normotensive subjects with isolated obesity (2005) (0)
Effect of insulin on systemic and renal permeability to albumin in nondiabetic and NIDDM subjects (1996) (0)
Insulin-induced stimulation of insulin secretion, its relation to insulin sensitivity and impact on impaired glucose regulation (2011) (0)
Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2017) (0)
Thyroid involvement in HCV-related cryoglobulinemic vasculitis (2005) (0)
Impairment of carbohydrate oxidation during atrial pacing in patients with syndrome X (1990) (0)
EMPA-REG OUTCOME®: Macrovascular and microvascular outcomes (2016) (0)
Empagliflozin Reduces Mortality in Patients with Type 2 Diabetes and a History of Left Ventricular Hypertrophy: A Sub-Analysis of the EMPA-REG OUTCOME Trial (2018) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (0)
P1876Empagliflozin reduces mortality in patients with type 2 diabetes and a history of left ventricular hypertrophy: a sub-analysis of the EMPA-REG OUTCOME trial (2018) (0)
Author response for "Effects of 6weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study" (2021) (0)
Insulin resistance and obesity as possible mechanism of preclinical cardiac involvement in normal population (2006) (0)
Impaired Myocardial Utilization of Lactate and Pyruvate in Different Patients with Microvascular Angina (1994) (0)
Overview of Glucose Homeostasis (2018) (0)
In overweight and obese subjects without comorbidities, visceral obesity appears an independent determinant of carotid remodeling but not stiffening. (2007) (0)
Abstract 10916: Mendelian Randomization Studies Do Not Support a Causal Effect of Plasma Lipids on Insulin Sensitivity (2012) (0)
Importance of route of glucose administration for hepatic glucose uptake in healthy subjects (1978) (0)
Author response for "Brain FFA uptake is elevated in morbid obesity, and is irreversible six months after bariatric surgery: a positron emission tomography study" (2020) (0)
RELATIONSHIP BETWEEN PHYSICAL EXERCISE, NITRIC OXIDE AND ENDOTHELIAL DYSFUNCTION IN OLDER AND YOUNG PEOPLE (2003) (0)
Synthesis and preclinical evaluation of iodine-125 and iodine-124 labelled human insulin (1999) (0)
A Model for Assessing Insulin Secretion Function During a 24 Hour Standardized Life Period (2000) (0)
Liver blood content and [F-18]FDG uptake by PET: Influence of dual vs single input function, and scan duration, during fast or hyperinsulinaemia (2004) (0)
2089-P: Regional Renal Hemodynamics and Fatty Acid Uptake: Effects of Obesity and Weight Loss (2019) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
Effects of the long-acting human GLP-1 analogue liraglutide on β-cell function in normal living conditions Received for publication 14 February 2007 and accepted in revised form 21 April 2007. (2007) (0)
Insulin resistance is an indipendent predictor of early diastolic myocardial dysfunction in uncomplicated obesity (2007) (0)
EFFECT OF INSULIN AND TOTAL PARENTERAL-NUTRITION ON CIRCULATING AMINO-ACIDS IN THE POSTOPERATIVE PERIOD (1993) (0)
Genome-Wide Association Identi ﬁ es Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes (2011) (0)
Carotid Artery Stiffness Decreases with Habitual Physical Activity in a Healthy Adult Population (2005) (0)
Relation between common carotid artery stiffness and framingham risk score: a clinical study by vascular ultrasound (2007) (0)
INHIBITION OF HEPATITIS C VIRUS TRANSLATION AND SUBGENOMIC REPLICATION BY SMALL INTERFERING RNAS DIRECTED AGAINST CELLULAR RNA BINDING PROTEINS (2004) (0)
Metabolomic profile of morbidly obese NAFLD: effect of weight loss by exenatide or diet (2019) (0)
Loss of 50% overweight substantially im proves insulin sensitivity in obese insulin-treated type 2 diabetic patients using a very low calorie diet (2006) (0)
Iodoinsulin kinetics in normal and diabetic subjects. II. Pathophysiological aspects. (1977) (0)
Suppurative spondylitis with pelvic abscess: localization by $sup 67$Ga scanning (1975) (0)
Editorial: Toward a Systems Biology of Insulin Secretion and Type 2 Diabetes (2006) (0)
TVoglitazone Reduces LDL Oxidation and Lowers Plasma E-selectin Concentration in NIDDM (1998) (0)
Mechanisms of post-prandial hypoglycaemia after Roux-en-Y gastricbypass (RYGB) and sleeve gastrectomy (LSG) (2014) (0)
Increased gluconeogenesis in NIDDM: Substrate contribution and modulation by lipolysis (1998) (0)
Toward a systems biology of insulin secretion and type 2 diabetes (2006) (0)
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. (2002) (0)
135-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Severe Renal Impairment (2020) (0)
[Insulin resistance: a target]. (1988) (0)
Mini review CXCR 3 , CXCL 10 and type 1 diabetes (2014) (0)
Insulin-resistance and triglycerides as independent predictors of the early macrovascular involvement in type 2 diabetic patients (2002) (0)
Mo-W2:7 Anti-inflammatory and pro-proliferative properties of rosiglitazone in fibroblasts from type 2 diabetic patients (2006) (0)
Endothelium-dependent vasodilation is reversibily impaired in subclinical hypothyroidism (2002) (0)
502 Beta cell function (insulin secretion) is impaired in patients with stable chronic heart failure (2004) (0)
Minutes of the 25th General Assembly of the European Association for the study of diabetes (2004) (0)
Pathophysiology: Loss of β-Cell Function (2012) (0)
Visceral Adiposity and Large Artery Stiffness in Healthy Obese Subjects: 6.17 (2005) (0)
136-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Moderate Renal Impairment (2020) (0)
Inhibition of beta-oxidation improves hepatic steatosis and metabolism in obese non-diabetic humans (2007) (0)
The quality of care of very low birth weight babies in Brazil (2007) (0)
FRI-283-Impact on NAFLD of long-term weight loss after bariatric surgery (2019) (0)
Carotid arterial flow control in hypertensive patients- analysis by wave intensity (2008) (0)
Empagliflozin and renal sodium-hydrogen exchange in healthy subjects. (2023) (0)
Effect of LT-4 therapy on left ventricular function in subclinical hypothyroidism. A randomized double-blind placebo controlled study. 12th International Thyroid Congress. KyotoInternational Conference Hall, October 22-27, 2000; Japan. (2000) (0)
Relationship between endogenous glucose production and insulin sensitivity in humans. (1999) (0)
The Editor takes leave (1997) (0)
Author response for "Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes" (2019) (0)
Iodoinsulin kinetics in normal and diabetic subjects. I. Data analysis and modelling. (1977) (0)
INVIVO EFFECT OF INSULIN ON INTRACELLULAR CALCIUM LEVELS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS (1993) (0)
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes (2003) (0)
Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are AssociatedWith Incident Type 2 Diabetes (2017) (0)
Organisation Section (2005) (0)
Obesity and blood pressure: explaining the relationship (2008) (0)
Modeling glucose kinetics in vivo in the human forearm. Rationale and a dual tracer study (1988) (0)
Response to Comment on Ferrannini and Rosenstock. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646 (2021) (0)
Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2018) (0)
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study (2022) (0)
1531-P: Spontaneous Ketonuria Is Associated with Reduced Incidence of Diabetes (2019) (0)
Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes (2018) (0)
Visceral adiposity, glucose and insulin but not whole body insulin sensitivity, are independent determinants of LV mass and function in normal middle-age caucasian population (2006) (0)
Full title: Impact of a mild decrease in fasting plasma glucose on β-cell (2016) (0)
Abstract 3152: Hyperdynamic Circulatory State And Volume Overload Without Left Ventricular Intrinsic Myocardial Dysfunction Is Detected In Normotensive Non Diabetic Patients With Morbid Obesity (2007) (0)
Left ventricular systolic and diastolic function is related to insulin sensitivity in type 2 diabetic patients (2001) (0)
Bariatric Surgery in Type 2 Diabetes (2013) (0)
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes. (2022) (0)
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review (2022) (0)
[Trigemino-facial and vestibulo-oculomotr reflexes during central depression induced by GHB (author's transl)]. (1974) (0)
Critical role of route of glucose administration on hepatic glucose (G) uptake (1978) (0)
Negative insulin feed-back in noninsulin-dependent diabetes mellitus. (1982) (0)
Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepadtis (NASH) (2002) (0)
Isolated morbid obesity is associated with hyperdinamic circulatory state ans subclinical impairment of left ventricular diastolic filling (2008) (0)
Disturbance of lymphocyte circulation byPseudomonas aeruginosa infection in oxazolone-sensitized mice (1979) (0)
Myocardial perfusion and metabolism in patients with arterial hypertension, LV hypertrophy and normal coronary arteries (1992) (0)
[Substrate competition: its role in insulin resistance]. (1986) (0)
Tissue Doppler and metabolic syndrome (2005) (0)
Track 9 Surgical treatment in the obese P314–P334 (2001) (0)
Relationship between muscle/adipose tissue morphology, insulin sensitivity and beta cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2014) (0)
Mechanisms of progression to type 1 diabetes Progression to diabetes in relatives of type 1 diabetic patients : mechanisms and mode of onset . Running title : Mechanisms of progression to type 1 diabetes (2009) (0)
Expression of thyrotropin and thyroid hormone receptors in the adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss (2010) (0)
12.10 Role of Sympathetic Activation on Changes of Brachial Artery Endothelial Function During Hyperinsulinaemia in Healthy Subjects (2008) (0)
Vitamin C and insulin resistance in essential hypertension. (1999) (0)
IN PATIENTS WITH SYNDROME-X OR ESSENTIAL-HYPERTENSION, MYOCARDIAL UTILIZATION OF LACTATE AND PYRUVATE IS SIMILARLY IMPAIRED, BUT THROUGH DIFFERENT MECHANISMS (1993) (0)
Novel factors in the regulation of beta-cell function. (2004) (0)
[Arterial hypertension, insulin resistance, and cardiovascular diseases]. (1990) (0)
Human adipocytes express P2X7 receptors able to modulate some inflammatory responses in subjects with metabolic syndrome (2010) (0)
Expression and localisation of CD38 in the human pancreas (2000) (0)
Introduction (1999) (0)
386 Ventriculo-arterial coupling in uncomplicated obesity: a wave intensity analysis study (2006) (0)
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state (1998) (0)
1127-P: SGLT2 Inhibition (SGLT2i) Mediated Urinary Glucose Excretion (UGE) Associations with Metabolic and Renal Hemodynamic Parameters (2019) (0)
Effect of chronic hyperglycemia and hyperinsulinemia on liver FFA metabolism Studies in glucose intolerant patients using positron emission tomography (2003) (0)
139-LB: The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS (2020) (0)
Hypertension in the Metabolic Syndrome (2005) (0)
Myocardial metabolism is different in syndrome X and C.A.D. patients during angina and ST depression (1991) (0)
Mechanism of Action and Metabolic Effects of Exenatide in Obesity (2013) (0)
Author response for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis" (2020) (0)
Hyperdinamic circulatory state and volume overload without left ventricular intrinsic myocardial dysfunction is detected in normotensive non diabetic patients with morbid obesity (2007) (0)
Increased gluconeogenesis in type 2 diabetes: Substrate contribution and modulation by lipolysis. (1999) (0)
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease (2023) (0)
and insulin sensitivity in essential hypertension Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance (2011) (0)
Removal of Catheter Distortion by Deconvolution: Multiple Tracer Studies of Glucose Kinetics in the Human Myocardium (1994) (0)
Hypertension and diabetes : therapeutic needs of a demanding patient : proceedings of the EASD Congress, Stockholm, Sweden, September 1995 (1996) (0)
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821. (2020) (0)
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and chronic hepatitis C. (2008) (0)
Splanchnic and liver glucose metabolism : an insulin dose-response study (2006) (0)
IgG N-Glycosylation Is Altered in Coronary Artery Disease (2023) (0)
[Changes in the mitotic activity in the thoracic portion of the neural canal due to the transplantation of a limb bud]. (1966) (0)
[Effect of major tranquilizing agents on the trigemino-facial reflex]. (1977) (0)
[Vestibulo-oculomotor and trigemino-facial reflexes and H-reflex in the course of central depression produced by sodium gamma-hydroxybutyrate]. (1975) (0)
[Study of the H reflex in the course of central depression induced with sodium gamma-hydroxybutyrate]. (1974) (0)
Motor action potential (M.A.P.) in the evaluation of uremic peripheral neurone damage: influence of middle molecules (M.M.). (1983) (0)
Effect ofischaemia on sensorypotentials ofnormal subjects ofdifferent ages (1973) (0)
[Effects of ischemia on orthodromic sensory conduction velocity of the median nerve in normal subjects of different ages. Preliminary note]. (1972) (0)
[Trigemino-facial reflexes in the course of central depression induced with gamma-hydroxybutyrate]. (1974) (0)
[Our experience with over 100 cases of carpal tunnel syndrome]. (1980) (0)
Neurophysiological findings in headache patients. Psychogalvanic reflex investigation in migraineurs and tension headache patients. (1987) (0)
Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2009): 2009 October 1–4, Rome, Italy (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eleuterio Ferrannini?

Eleuterio Ferrannini is affiliated with the following schools: